Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study-commentary
- PMID: 36692600
- DOI: 10.1007/s00330-023-09396-4
Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study-commentary
Comment on
-
Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study.Eur Radiol. 2023 Mar;33(3):2209-2217. doi: 10.1007/s00330-022-09115-5. Epub 2022 Sep 30. Eur Radiol. 2023. PMID: 36180645 Free PMC article.
Similar articles
-
Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study.Eur Radiol. 2023 Mar;33(3):2209-2217. doi: 10.1007/s00330-022-09115-5. Epub 2022 Sep 30. Eur Radiol. 2023. PMID: 36180645 Free PMC article.
-
Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.Surg Oncol. 2018 Mar;27(1):95-99. doi: 10.1016/j.suronc.2018.01.001. Epub 2018 Jan 8. Surg Oncol. 2018. PMID: 29549911
-
Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?Eur J Radiol. 2017 Nov;96:74-79. doi: 10.1016/j.ejrad.2017.09.014. Epub 2017 Sep 28. Eur J Radiol. 2017. PMID: 29103479
-
Breast MRI in DCIS size estimation, breast-conserving surgery and oncoplastic breast surgery.Cancer Treat Rev. 2021 Mar;94:102158. doi: 10.1016/j.ctrv.2021.102158. Epub 2021 Feb 2. Cancer Treat Rev. 2021. PMID: 33610127 Review.
-
The effect of margins on the clinical management of ductal carcinoma in situ of the breast.J Surg Oncol. 2008 Dec 15;98(8):579-84. doi: 10.1002/jso.21041. J Surg Oncol. 2008. PMID: 19072848 Review.
Cited by
-
Feasibility analysis of magnetic resonance imaging-based radiomics features for preoperative prediction of nuclear grading of ductal carcinoma in situ.Gland Surg. 2023 Sep 25;12(9):1209-1223. doi: 10.21037/gs-23-132. Epub 2023 Sep 19. Gland Surg. 2023. PMID: 37842532 Free PMC article.
References
-
- Kerlikowske K (2010) Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010:139–141. https://doi.org/10.1093/jncimonographs/lgq027 - DOI - PubMed - PMC
-
- Wright JL, Rahbar H, Obeng-Gyasi S et al (2022) Overcoming barriers in ductal carcinoma in situ management: from overtreatment to optimal treatment. J Clin Oncol 40:225–230. https://doi.org/10.1200/JCO.21.01674 - DOI - PubMed
-
- Duffy SW, Dibden A, Michalopoulos D et al (2016) Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study. Lancet Oncol 17:109–114. https://doi.org/10.1016/S1470-2045(15)00446-5 - DOI - PubMed - PMC
-
- Narod SA, Iqbal J, Giannakeas V et al (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1:888–896. https://doi.org/10.1001/jamaoncol.2015.2510 - DOI - PubMed
-
- Mannu GS, Wang Z, Broggio J et al (2020) Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988–2014: population based observational cohort study. BMJ 369:m1570. https://doi.org/10.1136/bmj.m1570
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical